TY - JOUR T1 - RJ Reynolds has not published a negative randomised clinical trial of Camel Snus for smoking cessation JF - Tobacco Control JO - Tob Control SP - 357 LP - 358 DO - 10.1136/tobaccocontrol-2016-052913 VL - 26 IS - 3 AU - Eunice E Neeley AU - Stanton A Glantz Y1 - 2017/05/01 UR - http://tobaccocontrol.bmj.com/content/26/3/357.abstract N2 - In 2009, RJ Reynolds Tobacco (RJR) created ‘The Smoker Cessation/Migration Study’, a randomised control trial, to compare Camel Snus to Nicorette nicotine replacement therapy (NRT) for smoking cessation over 1 year. RJR also examined the effect of providing information on the health benefits of switching from cigarettes to smokeless tobacco (ST).1 ,2RJR's clinical studies division,3 together with legal, financial, marketing and innovation teams,4 created the earliest protocols.The study had three arms, with 200 smokers in each: (1) Camel Snus with one-time relative risk ST information; (2) Camel Snus without ST information; and (3) Nicorette lozenges. All participants were given study products for 12 weeks to aid with smoking cessation.5 Biochemically-verified cigarette … ER -